Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Co-Labs Australia. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Co-Labs Australia or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Redefining Cancer Diagnostics: The Promise of Precision Oncology with Martin from Oncoparse | #13

48:11
 
Share
 

Manage episode 465881274 series 3552374
Content provided by Co-Labs Australia. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Co-Labs Australia or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Join us as we welcome Martin Thompson, the visionary CEO and founder of Oncoparse, who has transformed personal adversity into groundbreaking innovation in the fight against pancreatic cancer. From his journey as an electrical engineer to co-founding Lenexa Medical, Martin's story is a testament to the power of design-led thinking and interdisciplinary collaboration. Discover how the University of Melbourne's biodesign course is fostering a new wave of startups by pairing engineering and business students, all focused on addressing critical clinical needs.
Explore cutting-edge pancreatic cancer treatment through the lens of precision oncology, where we discuss the revolutionary promise of KRAS-targeted therapies and ctDNA-based approaches. Our conversation delves into how a collaborative ecosystem, bolstered by AI and data analysis, is driving forward the identification of oncogenic genes and shaping the future of cancer diagnostics. With the potential for exponential growth as more data becomes available, we're on the brink of transformative advancements that could redefine patient outcomes.
Navigating the challenging landscape of early-stage MedTech and BioTech funding in Australia, we discuss our vision for creating a supportive platform to empower innovation. In this chat, you'll learn about the hurdles and opportunities faced by one of our startups and also hear how initiatives like venture studios and alternative venture support pathways could serve to support more groundbreaking ideas. Through personal stories and Martin's unique perspective, this conversation allows us to understand his relentless drive to tackle significant health issues, motivated by a deep-seated desire to make a tangible difference in the world of cancer innovation.

Still Curious? Check out what we're up to:

Or sign up for our newsletter to keep in the loop.

This experimental and emergent podcast will continue adapting and evolving in response to our ever-changing environment and the community we support. If there are any topics you'd like us to cover, folks you'd like us to bring onto the show, or live events you feel would benefit the ecosystem, drop us a line at [email protected].
We're working on and supporting a range of community-led, impact-oriented initiatives spanning conservation, bioremediation, synthetic biology, biomaterials, and systems innovation.
If you have an idea that has the potential to support the thriving of people and the planet, get in contact! We'd love to help you bring your bio-led idea to life.
Otherwise, join our online community of innovators and change-makers via this link.

  continue reading

Chapters

1. Biodesign & Early Pancreatic Cancer Detection (00:00:00)

2. Precision Oncology and Data Analysis (00:10:48)

3. Expanding Cancer Diagnostics Technology Platform (00:16:07)

4. Supporting Early Stage Innovation Ecosystem (00:29:39)

5. Personal Journey in Cancer Innovation (00:37:13)

15 episodes

Artwork
iconShare
 
Manage episode 465881274 series 3552374
Content provided by Co-Labs Australia. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Co-Labs Australia or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Join us as we welcome Martin Thompson, the visionary CEO and founder of Oncoparse, who has transformed personal adversity into groundbreaking innovation in the fight against pancreatic cancer. From his journey as an electrical engineer to co-founding Lenexa Medical, Martin's story is a testament to the power of design-led thinking and interdisciplinary collaboration. Discover how the University of Melbourne's biodesign course is fostering a new wave of startups by pairing engineering and business students, all focused on addressing critical clinical needs.
Explore cutting-edge pancreatic cancer treatment through the lens of precision oncology, where we discuss the revolutionary promise of KRAS-targeted therapies and ctDNA-based approaches. Our conversation delves into how a collaborative ecosystem, bolstered by AI and data analysis, is driving forward the identification of oncogenic genes and shaping the future of cancer diagnostics. With the potential for exponential growth as more data becomes available, we're on the brink of transformative advancements that could redefine patient outcomes.
Navigating the challenging landscape of early-stage MedTech and BioTech funding in Australia, we discuss our vision for creating a supportive platform to empower innovation. In this chat, you'll learn about the hurdles and opportunities faced by one of our startups and also hear how initiatives like venture studios and alternative venture support pathways could serve to support more groundbreaking ideas. Through personal stories and Martin's unique perspective, this conversation allows us to understand his relentless drive to tackle significant health issues, motivated by a deep-seated desire to make a tangible difference in the world of cancer innovation.

Still Curious? Check out what we're up to:

Or sign up for our newsletter to keep in the loop.

This experimental and emergent podcast will continue adapting and evolving in response to our ever-changing environment and the community we support. If there are any topics you'd like us to cover, folks you'd like us to bring onto the show, or live events you feel would benefit the ecosystem, drop us a line at [email protected].
We're working on and supporting a range of community-led, impact-oriented initiatives spanning conservation, bioremediation, synthetic biology, biomaterials, and systems innovation.
If you have an idea that has the potential to support the thriving of people and the planet, get in contact! We'd love to help you bring your bio-led idea to life.
Otherwise, join our online community of innovators and change-makers via this link.

  continue reading

Chapters

1. Biodesign & Early Pancreatic Cancer Detection (00:00:00)

2. Precision Oncology and Data Analysis (00:10:48)

3. Expanding Cancer Diagnostics Technology Platform (00:16:07)

4. Supporting Early Stage Innovation Ecosystem (00:29:39)

5. Personal Journey in Cancer Innovation (00:37:13)

15 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play